Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Catty, it moved because of the extra funding. I sold 3000 at $1.99. You can bet that new investers have a lot more info than we are privy to. I am still holding strong with BPAX. Todays dip does not show long term growth, just profit taking like I myself did.
FOR IMMEDIATE RELEASE
BioSante Pharmaceuticals
NASDAQ: BPAX
BioSante Pharmaceuticals to Raise $18 Million
in Registered Direct Offering
LINCOLNSHIRE, Illinois (December 27, 2010) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received commitments from several institutional investors to purchase $18 million of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately $16.9 million after deducting placement agent fees and other offering expenses. BioSante has entered into securities purchase agreements with these investors pursuant to which BioSante has agreed to sell an aggregate of approximately 10.6 million shares of its common stock and warrants to purchase up to approximately 5.3 million additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.50 of a share of common stock, will be sold for a purchase price of $1.70, a premium to the closing price on the prior full trading day of Thursday December 23, 2010.
"We are pleased to have a commitment from these new and existing institutional investors," said Stephen M. Simes, BioSante's president and chief executive officer. "This additional funding from these high quality biotechnology institutional investors provides us with a strong cash position as we close out the year, ensuring our ongoing focus on our LibiGel® Phase III clinical study program. Our objective is to submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) by the end of 2011. LibiGel remains the lead pharmaceutical product in the U.S. in active development for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, and we continue to believe that LibiGel has the potential to be the first product approved by the FDA for this common and unmet medical need."
The warrants to purchase additional shares will be exercisable at an exercise price of $2.00 per share beginning immediately and will expire five years from the date that the warrants are issued. All of the securities were offered pursuant to an effective shelf registration statement. Proceeds from the transaction will be used for general corporate purposes, including continuing to fund BioSante's LibiGel Phase III clinical study program, as well as to seek opportunities for its GVAX cancer vaccines and other technologies. The offering is expected to be consummated by December 30, 2010, subject to customary closing conditions.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (NASDAQ: RODM), acted as the exclusive placement agent for the transaction. Roth Capital Partners, LLC, JMP Securities LLC, Oppenheimer & Co. Inc. and Trout Capital, LLC acted as financial advisors.
A shelf registration statement relating to the shares of common stock and warrants issued in the offering (and the shares of common stock issuable upon exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC") and has been declared effective. A prospectus supplement relating to the offering will be filed by BioSante with the SEC. Copies of the prospectus supplement and accompanying prospectus may be obtained directly from BioSante by contacting BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, Illinois 60069. Copies of the final prospectus supplement and accompanying prospectus relating to the offering also may be obtained from Rodman & Renshaw, LLC, 1251 Avenue of the Americas 20th Floor, New York, NY 10020 or by calling (212) 356-0549 begin_of_the_skype_highlighting (212) 356-0549 end_of_the_skype_highlighting. This announcement is neither an offer to sell nor a solicitation of an offer to buy any shares of common stock or warrants of BioSante. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, three of which have been granted orphan drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gelâ„¢, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at:
http://www.biosantepharma.com
For more information, please contact:
For Media:
McKinney Chicago
Alan Zachary
phone: (312) 944-6784 begin_of_the_skype_highlighting (312) 944-6784 end_of_the_skype_highlighting Ext.316 For Investors:
The Trout Group LLC
Tricia Swanson
E-Mail: tswanson@troutgroup.com
Phone: (646) 378-2953 begin_of_the_skype_highlighting (646) 378-2953 end_of_the_skype_highlighting
Forward-Looking Statements To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Forward email
I can not find anything past 48 hours.
We really could use some sort of announcement. My fav would be a buyout. We really should be in the $2.00 range.
Bought in May at $1.66. Shame its taken this long to just get back to those levels. Should have avg down, but I am avg down with stocks that are still dropping, lol
Go TSEM !!!
DONT BURY THIS. THE MORNING BOYS NEED TO RESPOND, OR NOT! LOL
The question that needs to be asked is if Andy owns stock in YESD (Like I would believe him anyway). Lets say BIEL sells the products to YESD for a penny a piece, or something very cheap. Now YESD makes all the profit. These two are known to be shady. So after many scams they have a legit product, but with so many stock splits, this baby will never be worth much. And now along comes YESD. Now the profit goes to YESD and whoever is involved with them.
If you disagree that this is not possible, then you are just a pumper "or worse" and not worthy of ever reading your posts again!
But go to any closeout store and you will find many many products that are legit, but dont find their niche!
Im saying the product is legit, just not management
I own BIEL, but Im not in to make a killing, just a player here!
Go pLAY POWERBALL, YOU MISSED YOUR SHOT!
What is CY?LD??
Sovran Self Storage Reports Second Quarter 2010 Results;
Sees Leasing Activity Improving
Sovran Storage (NYSE:SSS)
Historical Stock Chart
1 Month : July 2010 to August 2010
Sovran Self Storage, Inc. (NYSE:SSS),
a self storage real estate investment trust (REIT), reported operating results for the quarter ended June 30, 2010.
Net income available to common shareholders for the second quarter of 2010 was $15.8 million or $.57 per diluted share. Exclusive of a $7.5 million gain on the sale of 8 properties, net income available to common shareholders was $8.2 million or $.30 per diluted share. Net income available to common shareholders for the same period in 2009 was $6.3 million or $.28 per diluted share. Funds from operations (FFO) for the quarter were $.61 per fully diluted common share compared to $.66 for the same period last year. The impact of the Company’s $4 million share offering in October 2009 offset a significant decline in interest expense thereby contributing to the decline in per share FFO results.
OPERATIONS:
Revenues for the 345 stores owned by the Company for the entire quarter of each year increased by 0.2% from those of the second quarter of 2009, the result of a 20 basis point drop in average occupancy offset by a 40 basis point increase in rates, and solid improvements in other, non-rental revenues.
Read my post, not talking about you Momofflour!
Some of these posts really make me laugh!
I was # 4, lol. In since may 12th! Just reading since!
Here we go!
Lets all hope that good news is coming!
The question that needs to be asked is if Andy owns stock in YESD (Like I would believe him anyway). Lets say BIEL sells the products to YESD for a penny a piece, or something very cheap. Now YESD makes all the profit. These two are known to be shady. So after many scams they have a legit product, but with so many stock splits, this baby will never be worth much. And now along comes YESD. Now the profit goes to YESD and whoever is involved with them.
If you disagree that this is not possible, then you are just a pumper "or worse" and not worthy of ever reading your posts again!
Yes you did self!
I thought I was the only one who bought or watched AES, LOL
This cant be good news. The average Joe is not in the market right now. And those who were, have now gotten on the sidelines!
flatlinning?
They didnt say that the deal was only for what 1 salesman could stuff in his carry on. Not bashing, just having fun! And yes, any good news is a step in the right direction.
On the serious side. I plan on doing a 2 week headquarter and distribution undercover "vacation." Today,I own no shares of BGEM. But I plan on hitting about 5 of my stock plays or watchers. I'll be sitting outside of fences, drinking coffee and observing. And no this isnt obsessive, but with pinkies, youd be surprised what I have found out talking to businesses next door. BGEM is on my top 10 list, but I need to cut it to about 5, due to travel time, and my wife shopping and sightseeing time, lol.
While flipping any stock, I still do research. I have long term stocks, stocks to be flipped and dogs Im sitting on. I have quite a bit(by my standards) in play at all time.
Sometimes flippers change to long term overnite.
Although I have made money in the market, most of the time I call it wrong. Sell to early or late.
I didnt mean to bash your stock in any way, shape or form.
Also I know I shouldnt sit on the puppies, but this isnt my profession. So what the heck!I have a "regular" job. Stocks are my enjoyment. Sort of like when I used to play basketball or softball in the evenings. Or before that drink beer and chase girls. Now I read financials.
Ive been a trader of IWEB before. Time to flip it again. Like NOW right NOW.I'm am now going to set a buy price. Hope to sell by Thursday. LOL
Long hill upwards
I really think we have a quality product here with a consumers market that should buy these products. That said... great products with bad management doesnt always speak good to the stock price. How many companies with great or very good products go bankrupt because of bad or incompetant management? Management of BIEL have been around awhile and not to succesful. Now finally they have a good and marketable product. Can they drive this or should they sell out as soon as possible and let an expert make BIEL profitable? I'm for selling or we might not ever get to green. Once a con man always a con man!
Even in todays crazy market, BPAX should be over $2. I keep acquiring when every day I feel like I should be just playing this stock. I would be rich with the way this thing bounces.
Solid Co. but might need a buyout to jack this price.
Had a buy in yest at 1.89. It did not get filled.I Just lowered todays buy to 1.85. Hoping to hit a dip, and roll on this gem.
Dead Stock.... or just Dead Board?
Holding at sub $2.00. Will load up if/when drop to the 1.90 price again.
Macedonia Purchases Six ZNOSE Model 4500 Portable Instruments
NEWBURY PARK, CA -- (Marketwire)
05/25/10
Electronic Sensor Technology Inc. (PINKSHEETS: ESNR), a leading provider of ultra-fast vapor analyzers, announced today that it had received an order for six instruments from the Government of Macedonia. Electronic Sensor Technology ZNOSE® model 4500 was selected over the competition in an open tender. This purchase was part of an ongoing program by the government of Macedonia to strengthen customs enforcement and border security.
The ZNOSE is a very versatile, ultra-fast Gas Chromatograph (GC). It is used to detect a variety of explosives including: TNT, RTX, C4 and TATP and nerve agents such as Sarin and Mustard Gas. The ZNOSE is flexible and easy to use; a change of software enables it to detect illegal drugs including cocaine, heroin, morphine and ecstasy. Similarly the same instrument can detect the adulteration of food products such as milk contaminated by melamine. The ZNOSE is currently being used for environmental, food/beverage, petro-chemical, life science and Homeland Security applications. For more information, please visit our website at www.estcal.com.
About Electronic Sensor Technology:
Founded in 1995, Electronic Sensor Technology has developed and patented a chemical vapor analysis process. We believe that the Company's product line is positioned to eliminate key vulnerabilities in the homeland security market, specifically in maritime port, airport, and border security applications.
SEC Filings and Forward-Looking Statements
This press release includes forward looking statements, including the Company's expectations regarding its ability to develop and access capital markets and its ability to achieve expected results in the chemical detection and analysis industry. The forward looking statements are identified through use of the words "potential," "anticipate," "expect," "planned" and other words of similar meaning. These forward-looking statements may be affected by the risks and uncertainties inherent in the chemical detection and analysis industry and in the Company's business. The Company cautions readers that certain important factors may have affected and could in the future affect the Company's beliefs and expectations and could cause the actual results to differ materially from those expressed in any forward-looking statement made by or on behalf of the Company.
Contact info:
William Wittmeyer
EST, Inc.
805-480-1994 ext 103
650 714 0823 cell
Good Morning fellow miners!
.....Maybe 2011 will be the year for BIEL. Or maybe higher pps by at the latest July 2014!
I'm not here to get rich quick. I just want you guys to "invest" big, (think kids college ed or mortgage the house). I'm outta here at .19 if yas could help me out a bit. Any takers?
Bought more at $1.89
I gotta be a player here at these levels
China to clean its coal habitBy Xiao Yu
(China Daily)
PrintMailChina is trying to clean up its coal habit in an effort to reduce some of its environmental problems.
Coal accounts for over 70 percent of China's primary energy production and consumption. The country's use of it will likely reach 2.9 billion tons by 2020.
Coal-firing-related emissions constitute 80 percent of China's annual sulfur dioxide (SO2) emissions and 70 percent of its carbon dioxide (CO2) emissions.
The 11th Five Year Plan (2006-2010) for Coal Industry Development in China requires the coal industry to strengthen reforms in its industrial structure, take a sustainable path with a high utilization rates and reduce its environmental impacts.
Related readings:
China expected to reach green goal a year earlier
China exceeds target in closing 43% small coal-fired plants
A policy crackdown on energy-gorging industries
Clean coal technologies have become a key way to achieve such goals. "Clean coal technology should be adopted throughout the entire coal chain," said Huang Shengchu, president of China Coal Information Institute (CCII).
The Chinese government is promoting coal washing, to improve combustion efficiency and minimize ash production and pollution. But the extra cost involved in the related technology means many coal-fired power plants are reluctant to adopt it. Currently only 15 percent to 20 percent of them use it.
Huang, however, said coal washing is a relative cheap way to cut back pollution and that the government might need to implement relevant policies to encourage it.
Integrated Gasification Combined Cycle (IGCC) is another clean coal option.
In an IGCC system coal is not combusted directly but reacts with oxygen and steam to form a sort of syngas (synthesis gas). After being cleaned, it is burned in a gas turbine to generate electricity and to produce steam to power a steam turbine.
Carbon capture and storage (CCS) is a type of clean coal technology that involves capturing the carbon dioxide, preventing the greenhouse gas from entering the atmosphere, and storing it deep underground.
But the cost of capturing and storing one ton of CO2 is about $70 to $80, said Huang.
Although IGCC and CCS technologies are not widely commercialized so far, they have the potential to turn black coal into another green energy source and, as such, deserve attention and investment, said Huang.
Wan Gang, minister of Science and Technology, said in February that China would further cooperate with the US in IGCC and CCS technologies.
Huang added that China needs to construct more mine-mouth power plants, which are located quite close to coal mines, since such plants reduce energy expended during transportation.
Last December, the US-based Clean Coal Technologies Inc (CCTI) and Sino-Mongolia International Railroad Systems Co Ltd (SMIRSC) signed an agreement under which CCTI will provide technologies to China to produce clean coal
Good Morning Chart & WU!!